First, due to a lack of an ICI-treated HCC cohort, the differences between the DDR molecular subclasses (DDR1 and DDR2) and the DDR-high and DDR-low score groups could not be further verified. The gene discussed is DDR2; the disease is hepatocellular carcinoma.